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1. Introduction    
This chapter presents an overview of a research work carried out for the rapid manufacture 
of bioceramics (HA)/biopolymers (PLLA) composite scaffolds by means of Selective Laser 
Sintering (SLS) technique, to be used for bone tissue implantation aiming to replace and/or 
repair bone defects due to traumatised, damaged or lost bone.  
SLS is an Additive Manufacturing Technology (AMT) that selectively sinters powders of 
engineering materials, from solid or surface models created by a CAD - 3D file, by means of 
a CO2 laser and in a layer-by-layer basis. 
HA (hydroxyapatite) is a bioceramic used since several years for medical applications 
although being mainly processed by conventional methods (cast, machined or manually 
produced). 
In recent years ceramics and their composites are being used to augment or replace various 
parts of the body, particularly bone. Their relative inertness to the body fluids, high 
compressive strength, and aesthetically pleasing appearance led to the use of ceramics in 
dentistry as dental crowns. Some carbons have found use as implants, especially for blood-
interface applications, such as heart valves. Due to their high specific strength as fibbers and 
their biocompatibility, ceramics are also being used as reinforcing components of composite 
implants and for tensile loading applications such as artificial tendons and ligaments. 
Calcium phosphate based bioceramics have been in use in medicine and dentistry in the last 
thirty years, in several applications: dental implants, periodontal treatment, alveolar ridge 
augmentation, orthopaedics, maxillofacial surgery, and otolaryngology. Different phases of 
calcium phosphate ceramics are used depending upon whether a resorbable or bioactive 
material is desired. Porous hydroxyapatite has been studied for use in repairing large 
defects in bone. Implanted HA is slowly resorbed by the body over several years and 
replaced by bone. HA as the capability to form a direct chemical bond with hard tissues. On 
implantation of HA particles or porous blocks in bone, new lamellar cancellous bone forms 
within 4 to 8 weeks. Porous materials are used on bone compatible implants to encourage 
bony ingrowths. Therefore, pore size is of considerable biological importance. 
PLLA (Poly-L-lactic acid) is a biodegradable polymer. The interest in biodegradable 
polymeric biomaterials for biomedical engineering has increased dramatically during the 
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past decade, because this class of biomaterials has two major advantages that non-
biodegradable biomaterials do not have.  
First, these biomaterials don’t elicit permanent chronic foreign-body reaction due to the fact 
that the human body would gradually absorb them, and they do not permanently retain 
trace of residual in the implantation sites. Second, some of them have recently been found to 
be able to regenerate tissues (tissue engineering), through the interaction of their 
biodegradation with immunologic cells. Hence, surgical implants made from biodegradable 
biomaterials could be used as temporary scaffold for tissue regeneration.  
This approach toward the reconstruction of injured, diseased, or aged tissues is considered 
one of the most promising fields for this century. One of the bone formation strategies is to 
construct bio-scaffold, which allows bone reformation once it is surgically placed in bone-
defect. The bio-scaffold has to combine mechanical strength with biocompatibility and 
osteoinductiveness (induction of bone cells) and osteoconductiveness (cells attachment).  
A key requirement in many biomedical applications, including artificial bones, is a property 
called connected porosity. Green parts produced by the chosen SLS technology inherently 
have this property. While HA has been used in bone replacement and grafting for more than 
20 years, this material was a logical choice for this work. PLLA was chosen as a binder 
because it offers a higher degradation time and a low melting temperature when compared 
with other acid lactic biodegradable derivates. This biopolymer acts as a binder during the 
sintering operation, and afterwards improves the mechanical properties of the implants. 
In this research work CAD/CAM/CAE systems, AMT, biomaterials and medical imaging 
techniques were integrated and this enabled the production of anatomical models. This 
approach provides a direct method of producing HA-based scaffolds suitable for bone 
replacement or bone tissue engineering. 
2. Biomaterials 
Biomaterials are natural or synthetic materials, used to replace part of a living system or to 
function in intimate contact with living tissue. 
This group of materials includes: 
- Metals (e.g. titanium and its alloys, Co-Cr alloys, stainless steels, etc.); 
- Ceramics (e.g. alumina, zirconia, calcium phosphates, marine coral, nacre etc.); 
- Polymers (e.g. polyethylene, polypropylene, polyvinyl, poly(lactide acid); poly(glycolic 
acid), etc.); 
- Composites (e.g. carbon-carbon, wire or fibre reinforced bone cement, etc.). 
Some of these biomaterials are biodegradable or resorbable (e.g. hydroxyapatite, polylactides, 
or composites of both). 
The required properties of biomaterials, for artificial tissue engineering are: 
- Biocompatibility (does not induces immune response or inflammation); 
- Biodegradability (biodegrade for non-toxic components); 
- Sterilizability (able to be sterilisable); 
- Stability over timescales, allowing the growth of new tissues; 
- Adequate mechanical and physical properties; 
- Adequate manufacturing. 
A description of materials for use in the human body is shown in Table 1: 
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Materials Advantages Disadvantages Examples 
Polymers 
(nylon, silicone rubber, 
polyester, 
polytetrafuoroethylene, 
etc.) 
Metals 
(Ti and its alloys, Co-Cr 
alloys, stainless steels, Au, 
Ag, Pt, etc.) 
 
 
 
Ceramics 
(aluminium oxide, 
calcium phosphates 
including hydroxyapatite, 
carbon, etc.) 
Composites 
(carbon-carbon, wire or 
fibre reinforced bone 
cement) 
Resilient, easy to 
fabricate 
 
 
 
Strong, tough, 
ductile 
 
 
 
 
 
Very 
biocompatible, 
inert, strong in 
compression 
 
Strong, tailor-
made 
Not strong, deforms 
with time, may 
degrade 
 
 
May corrode, dense, 
difficult to make 
 
 
 
 
 
Brittle, not resilient 
 
 
 
 
Difficult to make 
Sutures, blood 
vessels, hip 
socket, ear, nose, 
other soft tissues 
 
Joint 
replacements, 
bone plates and 
screws, dental 
root implants, 
pacer and suture 
wires 
Dental, joint 
replacements, 
coating of dental 
and orthopaedic 
implants 
Joint implants, 
heart valves 
Table 1. Materials for use in the body (After Bronzino et al., 1995) 
This section will mainly focuses on the biomaterials used in the experimental work of the 
research (bioceramics and biopolymers). 
Calcium phosphate based bioceramics have been in use in medicine and dentistry in the last 
thirty years, in several applications: dental implants, periodontal treatment, alveolar ridge 
augmentation, orthopaedics, maxillofacial surgery, and otolaryngology. Different phases of 
calcium phosphate ceramics are used depending upon whether a resorbable or bioactive 
material is desired.  
Apatite is a natural calcium phosphate containing a little fluorine (Ca4 (Ca F) (PO4)3) or 
chlorine (Ca4 (Ca Cl) (PO2)3). It is found in granular limestone, igneous rocks and 
metalliferous ores.  
Hydroxyapatite (HA or HAp) is a complex phosphate of calcium (Ca (PO4)3OH) that occurs 
as a mineral and is the chief structural element of vertebrate bone. It is a very important 
material for bioceramics. 
One of the important research issues concerning HA is its mechanical behaviour limitation. 
In fact, brittleness, poor fatigue resistance, low tensile strength, and low fracture toughness 
value precludes HA from use in load bearing situations. 
Dense, porous, or particulate forms have been prepared. However, porous HA as an 
implant material, is preferred. The pores (100-300μm) allow bone to grow into implant, 
promoting mechanical fixation with the natural bone. Nevertheless, porosity and pore size 
can reduce the mechanical properties of HA ceramic. The minimum pore size of 
approximately 100-150μm has been established as necessary for the continued health of 
bony ingrowths. 
Porous hydroxyapatite has been studied for use in repairing large defects in bone. 
Implanted HA is slowly reabsorbed by the body over several years and replaced by bone. 
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HA has the capability to form a direct chemical bond with hard tissues. On implantation of 
HA particles or porous blocks in bone, new lamellar cancellous (soft) bone forms within 4 to 
8 weeks (Zan et al., 2010). 
Porous materials are used on bone compatible implants to encourage bony ingrowths. Pore 
size can be of considerable biological importance. Studies have shown (Hench, 1991; 
Chelule, 2002) that with pore sizes ≥ 150μm, in orthopaedic implants, bony ingrowths into 
the pores occur, and this is useful to anchor the implant. It was found experimentally that 
pores smaller than 75μm did not permit the ingrowths of bone tissue. Moreover, it was 
difficult to maintain fully viable osteons within pores in the 75-150μm size range. This large 
pore size is needed so that capillaries can provide a blood supply to the in-growth of 
connective tissues. Vascular tissues do not appear if pores < 150μm. If the micro-movements 
occur at the interface of a porous implant, the capillaries can be cut off, leading to tissue 
death, inflammation and destruction of interfacial stability (Hench, 1991). 
When a porous material is implanted in bone, the pores become filled first with blood, 
which clots, then with osteoprogenitor mesenchymal cells, then after about 4 weeks, bony 
trabeculae. The ingrowths bones then become remodelled in response to mechanical stress. 
The bony ingrowths process depends on a degree of mechanical stability in the early stages. 
If too much motion occurs, the ingrowths tissue will be collagenous scar tissue, not bone. 
The porous and dense HA materials show excellent biocompatibility after implantation. The 
porous material can only be used to replace those places in the skeleton which are not 
loaded or are loaded mainly in compression. The dense sintered material does not convert 
to natural bone after implantation (Chelule, 2002). 
Synthetic polymeric materials have been widely used in medical disposable supplies, 
prosthetic materials, dental materials, implants, dressings, extracorporeal devices 
encapsulates, polymeric drug delivery systems, and orthopaedic devices such as metal and 
ceramics substitutes. 
The most natural polymer is demineralised bone matrix (DBM), which is produced by 
decalcifying pieces of bone. Other popular synthetic biodegradable polymers are poly 
(lactide acid) (PLLA) and poly(glycolic acid) (PGA) (Gibson, 2003). 
The required properties of polymeric biomaterials are similar to other biomaterials, which 
are given in Table 2: 
 
Properties Description 
Biocompatibility 
 
Sterilizability 
Physical property 
Manufacturability 
Noncarcinogenesis, nonpyrogenicity, nontoxicity, nonallergic 
response. 
Autoclave, dry heating, ethylenoxide gas, radiation. 
Strength, elasticity, durability. 
Machining, moulding, extruding, fibre forming. 
Table 2. Requirements for biomedical polymers (After Bronzino et al., 1995) 
The biomedical applications of polymeric biomaterials are very large, as shown in Table 3. 
For implant applications special attention have be given to polyethylene (PE) and 
polymethylmetacrylate (PMMA). 
The effect of implantation on the behaviour of biocompatible polymers is given in Table 4. 
The interest in biodegradable polymeric biomaterials for biomedical engineering has 
increased dramatically during the past decade, because this class of materials has two major 
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Synthetic Polymers I. Applications 
Polyvinylchloride (PVC) 
 
Polyethylene (PE) 
 
Polypropylene (PP) 
 
Polymethylmetacrylate (PMMA)
 
Polystyrene (PS) 
Polyethylenterephthalate (PET) 
 
Polytetrafluoroethylene (PTFE) 
Polyurethane (PU) 
Polyamide (nylon) 
Blood and solution bag, surgical packaging, dialysis 
devices, catheter bottles, connectors, and cannulae. 
Pharmaceutical bottle, no woven fabric, catheter, pouch, 
flexible container, and orthopaedic implants. 
Disposable syringes, blood oxygenator membrane, 
suture, no woven fabric, and artificial vascular grafts. 
Blood pump and reservoirs, membrane for blood 
dialyser, implantable ocular lens, and bone cement. 
Tissue culture flasks, roller bottles, and filter wares. 
Implantable sutures, mesh, artificial vascular grafts, and 
heart valve. 
Catheter and artificial vascular grafts. 
Film, tubing, and components. 
Packaging film, catheters, sutures, and mould parts. 
Table 3. Biomedical applications of polymeric materials (After Bronzino et al., 1995) 
 
Polymers II. Effects of Implantation 
Polyvinylchloride (rigid) 
Polyethylene (PE) 
 
Polypropylene (PP) 
Polymethylmetacrylate 
(PMMA) 
 
 
Polyethylenterephthalate 
(PET) 
Polytetrafluoroethylene 
(PTFE) 
Silicone rubber 
Polyamide (nylon) 
Tissue reaction, plasticizers may leach out and become brittle. 
Low-density ones absorb some lipids and lose tensile strength; 
high-density ones are inert, and no deterioration occurs. 
Generally no deterioration. 
Rigid form: crazing, abrasion, and loss of strength by heat 
sterilization. Cement form: high heat generation, unreacted 
monomers during and after polymerisation may damage 
tissues. 
Susceptible to hydrolysis and loss of tensile strength. 
Solid specimens inert; if fragmented, irritation will occur. 
No tissue reaction, very little deterioration. 
 
Absorb water and irritate tissue, lose tensile strength rapidly. 
Table 4. Effect of implantation on polymers (After Bronzino et al., 1995) 
advantages that non-biodegradable biomaterials do not have. First, these biomaterials don’t 
elicit permanent chronic foreign-body reaction due to the fact that the human body would 
gradually absorb them, and they do not permanently retain trace of residuals in the 
implantation sites. Second, some of them have recently been found to be able to regenerate 
tissues (tissue engineering), through the interaction of their biodegradation with 
immunologic cells. Hence, surgical implants made from biodegradable biomaterials could 
be used as temporary scaffold for tissue regeneration. 
This approach toward the reconstruction of injured, diseased, or aged tissues is considered 
one of the most promising fields of this century (Stevens, 2002). 
The most commercially significant biodegradable polymeric biomaterials are originated 
from: 
www.intechopen.com
 Biopolymers 
 
232 
- Glycolic acid (e.g. polyglycolide (PG), polyglycolic acid (PGA)); 
- Lactic acid (e.g. polylactide (PLA), poly-L-lactide (PLLA)). 
Their biomedical applications have been limited to mainly orthopaedic surgery, drug 
control/release devices, coating materials for suture, vascular grafts, and surgical meshes to 
facilitate wound healing after dental extraction. 
PLLA is a biodegradable semi-crystalline polymer derived from lactic acid (C3H6O3). 
Lactic acid is a natural organic acid. Long before it became commercially available lactic acid 
was formed by natural fermentation in products such as cheese, yoghurt, soy sauce, meat 
products, pickled vegetables, beer and wine. Animal and human bodies also produce 
significant amounts of L (+) lactic acid during daily activities such as walking and running. 
Today, lactic acid, its salts and esters are extensively used in food, industrial, cosmetic, 
medical and pharmaceutical industries. It is produced by fermentation of sugar and water 
or by chemical process and is commercially sold as a liquid. Lactic acids are optically active 
compounds including L-and D- forms. 
Applications of this polymer in medicine and pharmacy include wound closure products, 
drug delivery systems and surgical implant devices. The main advantages of these polymers 
are their mechanical strength, combined with biodegradability and biocompatibility. The 
biodegradation of PLLA takes place by random hydrolysis, being the final degradation 
products eliminated by natural way. 
 
 
Fig. 1. PLLA image (Designinsite, 2001) 
PLLA presents an extremely slow biodegradation rate at body temperature (> 24 months).    
This biopolymer has a Tm = 170°C and a Tg = 56°C. The high Tg is mainly responsible for the 
mentioned slow degradation rate. It resembles clear polystyrene as can be seen in Figure 1.  
Recently, biodegradable polymers, e.g. polylactic acid (PLA) have been used to treat 
minimally loaded fractures, thereby eliminating the need for a second surgery for implant 
removal. 
Because metals are too stiff to prevent stress protection, polymers tend to be too flexible and 
to weak to meet the mechanical demands for an internal fixation device, and bioceramics (e. 
g. HA) are to brittle and have unfavourable mechanical properties where weight bearing is 
concerned, composite materials should be considered for this purpose. 
Composite materials are solids that contain two or more distinct constituent materials or 
phases, on a scale larger than the atomic. 
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Natural composites include bone, wood, dentin, cartilage and skin. In biomaterials, e.g. 
HA/PLLA composites, each constituent of the composite must be biocompatible. Moreover, 
the body environment should not degrade the interface between constituents.  
Composite materials can be made having carefully tailored properties for specific 
engineering performance and design requirements whether these are mechanical, biological, 
chemical, or electrical. 
The property of the composite is related to the properties and proportions of the composite 
constituents and the interface between those constituents. Composites can be produced with 
a high specific modulus and an advantageous strength-to-weight ratio. Composites can also 
often have superior toughness since the filler fibres or particles can deflect or stop the 
process of a crack. This is reflected in a higher strength of the composite compared to that of 
the matrix material alone. In addition, the filler can confer certain biological properties, such 
as bioactivity, when incorporated into the composite in appropriate amounts. Bioactive 
materials, e.g. hydroxyapatite and various bioactive glasses and glass-ceramics, are 
generally renowned for low toughness and tensile strength. 
The properties of the composites (density, stiffness, chemical activity, and possibly 
biological activity) are determined by the Rule of Mixtures. 
Many of the synthetic biocomposites are used in orthopaedics to reconstruct or augment 
living bone. 
In Table 5 the classes of materials that can be used in biocomposites are shown: 
 
Possible matrices Possible fillers 
Thermoplastics 
Thermosets 
Ceramics 
Metals 
Glasses 
Carbon 
Ceramics 
Metals 
Polymers 
Table 5. Classes of materials that could either be used as fillers or matrices (After Yamamuro 
et al., 1990) 
For bone reconstruction different composites can be used, as shown in Table 6. 
Because metals are to stiff to prevent stress protection, polymers tend to be too flexible and 
to weak to meet the mechanical demands for an internal fixation device, and bioceramics (e. 
g. HA) are to brittle and have unfavourable mechanical properties where weight bearing is 
concerned, composite materials should be considered for this purpose. Recently attention 
has been paid to the application of HA in combination with a polymeric substance. The use 
is still confined to the field of the filling of bony defects and as drug carrier. Polyethylene, 
polybyturate and PLLA are the most frequently used polymers in such composite materials.  
Recently attention has been paid to the application of HA in combination with a polymeric 
substance. The use is still confined to the field of the filling of bony defects and as drug 
carrier. Polyethylene, polybyturate and PLLA are the most frequently used polymers in 
such composite materials. 
Composites of HA / PLLA combines bioresorption (PLLA) with bone bonding potentials 
(HA) resulting in a potentially bioactive and bioresorbable composite with higher strengths 
and stiffness than the unfilled polymer (Ignjatovic et al., 1999; Kesenci et al., 2000). 
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Type of system Composite 
Stable systems Epoxy resin / carbon fibre 
Polysulfone / carbon fibre 
Epoxy resin / alumina / stainless steel 
Polymethylmethacrilate / polyaramid 
Polyethylene / carbon fibre 
Carbon fibre-reinforced carbon 
Bioactive systems Epoxy resin / Bioglass® 
Collagen / hydroxyapatite 
Polyethylene / hydroxyapatite 
Polymethylmethacrilate / phosphate / silicate / apatite (CPSA) 
glass fibre 
Polymer / phosphate glass 
Hydroxyapatite / collagen  + gelatin - resorcinol - formaldehyde 
Degradable systems Polylactic acid / glycolic acid / with self-reinforcement 
Polyhydroxybutirate / hydroxyapatite 
Polylactic acid / glycolic acid / hydroxyapatite 
Table 6. Composites for bone reconstruction (After Yamamuro et al., 1990) 
Figure 2 shows new bone formation surrounding an implant of HA/PLLA after 32 weeks: 
 
New bone 
HA/PLLA implant 
 
Fig. 2. HA/PLLA implant (Biocomposites, 2001) 
3. Selective Laser Sintering 
The Selective Laser Sintering (SLS) process belongs to the solid-based Additive 
Manufacturing Technologies, which primarily use powder as the basic medium for 
manufacture. The objects are built layer by layer by sintering / interfusing thin layers of 
powder. Each layer fuses to the previous one creating a physical object.  
Thus, the Selective Laser Sintering process creates three-dimensional objects, layer by layer, 
from powdered materials, with the heat generated by a CO2 laser within the apparatus 
(Sinterstation System). First, three dimensional CAD data must be output in the industry-
standard .STL (Standard Triangulation Language) format. 
The process comprises 4 phases: 
- As the selective laser sintering process begins, a thin layer of the heat-fusible powder is 
deposited into the part build chamber; 
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- An initial cross-section of the object under fabrication is selectively “drawn” (or 
scanned) on the layer of powder by a heat-generating CO2 laser. The interaction of the 
laser beam with the powder elevates the temperature to the point of melting, fusing the 
powder particles and forming a solid mass, i.e., sinters the powder particles (heats and 
bonds selected portions of each layer). The intensity of the laser beam is modulated to 
melt the powder only in areas defined by the object’s design geometry; 
- An additional layer of powder is deposited, via a roller mechanism, on top of the 
previously scanned layer; 
- The process is repeated, with each layer fusing to the layer below it. Successive layers of 
powder are deposited and the process is repeated until the part is complete. 
After the building the part is removed from the build chamber and the loose powder falls 
away. Parts may then require some post-processing, such as sanding, depending upon the 
intended application. 
There is no need to create support structures with the CAD design prior to or during 
processing and, therefore, no support removal is needed when the part is complete.  
The software components of the Sinterstation System include a Unix operating system and 
proprietary application software. 
In Figure 3 a schematic view of the Sinterstation Process Chamber is present: 
 
 
Fig. 3. Process Chamber of the SLS Sinterstation System  
The main aspects to be considered in the SLS technology are the properties of the powders 
used in the process and the fabrication parameters.  The fabrication parameters depend 
strongly on the materials used, and have significant influence in the mechanical properties 
(e.g. tensile strength, surface hardness and density), dimensional accuracy and surface 
quality (i.e. roughness) of the parts produced. With SLS it is not possible to achieve the best 
quality in appearance with the best mechanical properties. Maximum density of the parts is 
only achieved with parameters that result in excess powder sticking to the surface and low 
speed of construction (which is time-consuming). Using the correct combination of coating 
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and finishing in post-processing, the mechanical properties and surface of SLS parts can be 
improved. 
A large range of materials is available for this process. Basically, any substance that can be 
grounded to a fine powder may be employed. At present there are 12 commercially 
available powders that can be used in the SLS process. The most used are nylon 
(polyamides), nylon composites (glass fibre nylon), polystyrene and polycarbonate. They are 
non-toxic, safe, and can be sintered with relatively low power lasers (10-20W). 
The main SLS process variables are: part bed temperature, laser power, scan size, scan 
spacing, slice thickness, and part position and orientation (3D Systems, 2003). 
4. Experimental work 
In this section an overall view of the experimental work is presented. 
Based on previous screening trials, a choice of 40% ratio of PLLA by weight has been made. 
This choice was based on the fact that adding lower than 30% wt. of PLLA to HA will not 
add significantly for the biodegradation or to enhance the ductility properties, and higher 
than 50 % wt. the implant could be too plastic and therefore not behave as bone tissue (Cruz, 
2005). 
4.1 Materials 
The materials used in this work (in powder form) were as follows:  
- HA: Captal® 120 grade – sintering powder, supplied by Plasma Biotal Limited (UK), 
with mean particle size (D50) of 111±5µm, melting point of 1250 (-0 +50) °C and 1.30 
g/cm3 of density (~£300 /Kg); 
- PLLA: Purasorb® L, supplied by PURAC (The Netherlands), with mean particle size 
(D50) of 163±5µm (after sieving), melting range of 182.4 – 192.3°C and 0.47 g/cm3 of 
density (after sieving) (~£1700 /Kg). 
4.2 Equipments 
The experiments were performed on a SLS Sinterstation 2000 (3D Systems™, USA) apparatus 
installed at CRDM (Centre for Rapid Design and Manufacture), High Wycombe, UK.  
This apparatus was modified, namely the feeding envelopes and the part platform, to allow 
operating with non-standard materials (as the standard material is nylon), and with small 
amounts of HA/PLLA (1Kg instead of the standard 20Kg) due to cost control of testing. 
In Figure 4 a general view of the SLS apparatus used in the experimental work is presented. 
4.3 Method 
The aim of the first phase of the experimental work was to identify those factors (process 
parameters) that have large effects on the response variables (physical properties of the 
parts produced). In this phase a screening experimental design and analysis, based in the 
fractional factorial design technique, was applied to determine the most influential factors of 
interest on fabrication of HA/PLLA models by SLS. A DoE (Design of Experiments) 
methodology was used (Montgomery, 1997). 
The results obtained in the tests were focused on three (3) response variables (density, 
geometric accuracy and surface quality of the parts produced).  
The results obtained in the screening analysis show that the three factors with most 
influence on the physical properties of the parts produced by SLS were laser power, scan 
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speed and scan space, i.e., the Applied Energy Density (AED). In fact, these three factors 
together constitute the Andrew’s Equation (Cruz, 2005), corresponding to the energy 
density applied to the powder bed, which determines the scanning strategy during the SLS 
operation.  
 
 
 
Fig. 4. The SLS Sintersation 2000 apparatus (Courtesy of CRDM) 
After this preliminary stage of the experimental work, the next step was focused on the 
measurement of the ultimate compressive strength and the elastic modulus in compression, 
as well as the bending strength and modulus of the parts produced, by means of a 2k full 
factorial design and analysis, in order to achieve more detailed information about the most 
influent factors selected in the previous phase. 
A 23 full factorial design was applied (Montgomery, 1997). The objective was to obtain a 
mathematical equation to express the effects of the AED in the ultimate compressing 
strength, bending and density of HA/PLLA specimens. 
A design consisting of sixteen (16=8+8) experiments (i.e., a 23 experimental design: 3 
independent variables at 2 levels each, with one (1) genuine replicate added to the design) 
was conducted in a randomised sequence. 
The experimental design was conducted according with the data presented in Table 7 (Cruz, 
2005): 
 
 
Table 7. Data for the 23 factorial design 
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To investigate the degradation behaviour of the HA/PLLA parts produced by SLS, namely 
its PLLA component, in vitro tests were performed. To study the in vitro degradation 
mechanism of the HA/PLLA specimens, an aqueous media (physiological fluid) – saline 
phosphate buffer (SPB, pH=7.4) was used. This media has been taken as a model of 
biological fluids (Taddei et al., 2002). The study was conducted on their physical properties, 
namely their mass loss along the time (six months). 
5. Results 
In the following Table 8 and Figures 5 to 7, the main results obtained are summarized (Cruz, 
2005): 
 
Table 8. Comparison of properties between HA/PLLA parts and human bone 
 
 
Fig. 5. SEM image of a HA/PLLA part with measurement of internal porosity (Example in 
the Z direction - magnification 100x) 
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Fig. 6. HA / PLLA scaffolds as SLS produced 
 
 
Fig. 7. Percentage of mass loss versus time 
6. Discussion 
The main goal of the experimental work was to demonstrate the feasibility of producing 
HA/PLLA parts by selective laser sintering. The results were successful in proving that 
feasibility. 
In fact, the main results of the trials performed, have shown that: 
- It is possible to produce bioceramic parts (HA based) by means of AMT - Additive 
Manufacturing Technologies, namely the Selective Laser Sintering (SLS) process, using 
a biocompatible/biodegradable polymer as binder; 
- For that purpose it is necessary to use a polymeric binder (40% wt.) to promote the 
agglomeration of the ceramic particles during the laser operation (sintering). The 
component, in this phase, is the so-called “green body”; 
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- In the case of using a biocompatible binder (e.g. PLLA), the blend HA/PLLA produces 
a part that can be used directly in the body without removal of the binder (green body). 
This technique is a direct route to fabricate laser sintered HA based ceramic parts for 
medical purposes; 
- Thus, this route allows the production of parts directly, without the need of post-
process operations, therefore reducing the time and cost of production;  
- In such a case the mechanical properties of the parts produced constitutes a major 
limitation, allowing their application only in non-load bearing situations or supported 
load bearing uses; 
- The internal porosity of the HA/PLLA parts produced (mean value >150μm) is suitable 
to promote the growth of new tissues in the implant. In fact, this condition is essential 
to allow extensive blood supply of the new bodies, providing a rich supply of cells, 
growth factors and other nutrients needed to make bone grow. Moreover, these small 
holes allow access of bone marrow elements from the host tissues to the bone graft, 
providing nutrients for bone healing; 
- The density of the HA/PLLA sintered parts (mean value = 0.883 g/cm3) is within the 
density range values for the cancellous bone (0.14 to 1.10 g/cm3) as previously referred.  
It can be seen that the green density in nearly the same of the powder bed. 
This result is important because, in principle, the higher the density of bone implant, 
the larger its strength. 
The results obtained by applying the full factorial design have shown that the mechanical 
properties of the HA/PLLA parts as SLS produced are relatively poor when compared with 
other biomaterials (σc between 2.44 and 4.57 MPa / Ec between 17.19 and 40.80 MPa), but, 
even so, the Ultimate Compressive Strength and the Elastic Modulus lie in the lower limits 
of reported values for cancellous bone (1.5 – 38 MPa and 10 – 1570 MPa, respectively). 
These results confirm the low mechanical strength of the HA/PLLA parts, as SLS produced, 
thus constituting a limitation for the applications in load-bearing situations. 
The mechanical properties of the HA/PLLA sintered parts by SLS are expected to rise with 
the optimisation of the various parameters involved, particularly the energy density applied 
and the grain dimension of the starting powder. 
7. Recommendations 
It is believed that the investigation carried out can give guidance for other researchers 
interested in this subject. For successful SLS with HA powder and binder, the following care 
must be taken: 
- Particle size is very important as it decides good powder spread with dense structure 
for component strength; 
- When using coarse particles the friction between successive layers is higher, not 
allowing the correct spreading of the powder in the part platform during the build. In 
some cases a kind of “powder wave” can originate the displacement of the part being 
built; 
- Also, the higher the particle size the higher the surface roughness and the lower the 
surface definition and the strength of the components; 
- To avoid those phenomena it is recommended that powders be used with grain size in 
the range 80–120 μm, though the grinding of ductile polymers is problematic. 
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Therefore, an investigation into methods for reducing PLLA raw granules in order to 
obtain particles in that size range is necessary. The use of a ball mill for ground blends 
of HA coated with PLLA (produced using emulsions) is a possible solution; 
- Although no references have been found in literature, and in testing, the possible 
existence of carbon in the HA matrix, as a result of the burning from the laser of the 
organic portion of the PLLA binder, is a concern. The effect of carbon on the behaviour 
of the implant is not fully understood, but some researchers suggest that it can have a 
possible negative influence either on the living tissues around the implantation area 
(eventual inflammation) or by the generation of hard spots in the implant matrix 
(eventually promoting a fragile structure). The thermal analysis performed didn’t 
indicate any signs of carbon. The use of high temperature DSC (Differential Scanning 
Calorimeter) is therefore recommended for that purpose. The use of such equipment 
was not possible during the time of this research. 
8. Conclusion 
The major contribution of this research is the establishment of data and formulation of 
guidelines for the rapid manufacture of hydroxyapatite based components, by means of the 
SLS technology, to be used for bone tissue implantation, to replace and/or repair bone 
defects, due to traumatised, damaged or lost bone. 
The overall feasibility of producing hydroxyapatite based bone shapes, from SLS, has been 
established. 
While potentially very biocompatible, the porous calcium phosphate/poly-lactide implants 
are probably not strong enough for load bearing applications, such as artificial hips, bone 
screws, or dental implants. This is a limitation of the SLS technology, due to the fact that this 
process cannot produce directly full-density implants because it always yields porous parts.  
This bioactive and resorbable composite (HA/PLLA) can be a potential improvement of the 
currently used internal fixation devices in orthopaedic surgery, because bone healing is a 
dynamic process and such a material should be resorbable to insure a progressive stress 
transfer to the bone. 
This approach will allow the promotion of autograft (i.e., the patient’s bone reconstruction), 
bone reconstruction, eliminating the need of using allograft bone graft substitutes (i.e., cadaver 
bone obtained from a tissue bank), thus reducing the chance of remote risk of disease 
transmission that all forms of allograft carry. A synthetic replacement is a major contribution 
for eliminating such problems. 
The use of biodegradable polymers is, nowadays, still quite expensive, which can constitute 
a major drawback for the application of this type of products in bone reconstruction, 
although the good potentialities presented for that purpose. 
The main advantages of RM (Rapid Manufacturing) of medical implants are: to reduce the 
number of patient visits prior to the surgery, remove time consuming operations, and 
reduce prostheses construction times. 
The research has shown that the additive fabrication of biomaterials is possible with an 
adequate accuracy, strength and geometry of the models produced. The main advantages of 
using AMT to produce medical implants include the reduction of patient’s visits prior to the 
surgery, remove time consuming operations, and reduce prostheses construction times. The 
mechanical properties (i.e., the compressive strength, compressive elastic modulus, bending 
strength and bending modulus) of the sintered SLS specimens produced in this research are 
www.intechopen.com
 Biopolymers 
 
242 
lower than that of cortical bone and pure solid sintered HA, but acceptable when compared 
with the mechanical properties of cancellous bone. In vitro studies have shown a slow 
degradation rate, and a good biocompatibility of the parts, as SLS produced, meaning that 
the implants can act as a good scaffold for bone ingrowths. 
Thus, this bioactive and resorbable composite (HA/PLLA) can be a potential improvement 
of the currently used internal fixation devices in orthopaedic surgery, because when bone 
healing is a dynamic process such a material should be resorbable to insure a progressive 
stress transfer to the bone. 
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